课题基金 / 基金详情

Developing novel smart biointerfaces for in vitro biosensing and point of care diagnostics

Developing novel smart biointerfaces for in vitro biosensing and point of care diagnostics
开发用于体外生物传感和护理诊断的新型智能生物接口
批准号:
537197-2018
负责人:
Didar, Tohid
金额:
$14.57万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Didar, Tohid的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project, we propose to design a new class of immunodiagnostic-based biosensors that are more precise and functional than conventional biosensors. We will do this using our novel technique in preparation of the sensors' bio-interfaces where we utilize the lubricant-infused-surface technology in order to enhance the sensor's functionality. Our new surface modification techniques allow us to obtain surfaces that have a superior ability in detecting very low concentrations of the desired bio-species in complex environments such as blood and blood plasma. We will employ these biosensors in detecting low-molecular weight proteins such as Interleukin 6 which plays a crucial role in early detection of a variety of cancers as well as inflammatory diseases and immunotherapy. The other objective of this project is producing point-of-care diagnostic biosensors by incorporating microfluidic systems. These portable devices can facilitate the detection of the related diseases in a rapid and straightforward, yet precise manner. Creation of functional antibodies referred to as "biofunctional inks" is another goal of this proposal. This product can target a wide range of biosensor industries and biomedical applications, where sensor's robustness, ease of fabrication, and versatility are desired. We intend to commercialize our final products in collaboration with our industry partner, SQI Diagnostics Inc. We will investigate the long-term stability of the developed biosensors and determine the proper storage conditions of the products. Further, we will design high throughput production lines with in-line quality control systems for the fabrication of the biosensors and other side products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nano-biomaterials
  • 批准号:
    CRC-2020-00094
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $8.74万
  • 财政年份:
    2022
  • 负责人:
    Didar, Tohid
  • 依托单位:
Engineering the bio-interface for the next generation of biomedical devices
  • 批准号:
    RGPIN-2017-05254
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.35万
  • 财政年份:
    2022
  • 负责人:
    Didar, Tohid
  • 依托单位:
Engineering the bio-interface for the next generation of biomedical devices
  • 批准号:
    RGPIN-2017-05254
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $1.68万
  • 财政年份:
    2021
  • 负责人:
    Didar, Tohid
  • 依托单位:
Nano-Biomaterials
  • 批准号:
    CRC-2020-00094
  • 项目类别:
    Canada Research Chairs
  • 资助金额:
    $8.74万
  • 财政年份:
    2021
  • 负责人:
    Didar, Tohid
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: